Buscar resultados de ensayos clínicos
Primary Biliary Cholangitis - 16 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: Seladelpar 10 mg one capsule daily for up to 52 weeks |
| COMPLETED |
Nombre del estudio: Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) |
| COMPLETED |
Nombre del estudio: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: Seladelpar 10 mg single oral dose |
| COMPLETED |
Nombre del estudio: A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: K-808 single or multi dose extended-release tablets |
| COMPLETED |
Nombre del estudio: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: Single oral dose of CS0159 4mg |
| COMPLETED |
Nombre del estudio: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC Condición: Primary Biliary Cholangitis Fecha: 2025-11-04 Intervenciones: One tablet of bezafibrate 100 mg IR once daily |